Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients.

  • Authors : Mitchell J; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Connolly CM

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; 2019-nCoV Vaccine mRNA-1273

  • Source: JAMA network open [JAMA Netw Open] 2022 May 02; Vol. 5 (5), pp. e2211897. Date of Electronic Publication: 2022 May 02.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Vaccine Uptake in the US After Full Food and Drug Administration Approval of the BNT162b2 mRNA COVID-19 Vaccine.

  • Authors : Bailey EV; Department of Population Health Sciences, University of Utah, Salt Lake City.; College of Social and Behavioral Science, University of Utah, Salt Lake City.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; BNT162 Vaccine

  • Source: JAMA network open [JAMA Netw Open] 2022 Apr 01; Vol. 5 (4), pp. e226108. Date of Electronic Publication: 2022 Apr 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Report

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.

  • Authors : Botton J; EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France.; Semenzato L

Subjects: Hospitalization* ; Vaccine Efficacy*; Ad26COVS1/Ad26COVS1/Ad26COVS1/*therapeutic use

  • Source: JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e220868. Date of Electronic Publication: 2022 Mar 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents.

Subjects: Vaccine Efficacy*; BNT162 Vaccine/BNT162 Vaccine/BNT162 Vaccine/*administration & dosage ; COVID-19/COVID-19/COVID-19/*prevention & control SARS-CoV-2 variants

  • Source: JAMA network open [JAMA Netw Open] 2022 Mar 01; Vol. 5 (3), pp. e220935. Date of Electronic Publication: 2022 Mar 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine.

Subjects: Influenza Vaccines* ; Influenza, Human*/Influenza, Human*/Influenza, Human*/epidemiology ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & control

  • Source: JAMA network open [JAMA Netw Open] 2023 Nov 01; Vol. 6 (11), pp. e2342151. Date of Electronic Publication: 2023 Nov 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults.

  • Authors : Harris DA; Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island.; Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.

Subjects: Frailty*/Frailty*/Frailty*/epidemiology ; Frailty*/Frailty*/Frailty*/etiology ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: JAMA network open [JAMA Netw Open] 2023 Aug 01; Vol. 6 (8), pp. e2326852. Date of Electronic Publication: 2023 Aug 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.

  • Authors : Cassidy AG; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco.; Li L

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Female

  • Source: JAMA network open [JAMA Netw Open] 2023 Jul 03; Vol. 6 (7), pp. e2323405. Date of Electronic Publication: 2023 Jul 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.

  • Authors : Zedan HT; Biomedical Research Center, Research Complex, Qatar University, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.

Subjects: Middle East Respiratory Syndrome Coronavirus* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: JAMA network open [JAMA Netw Open] 2023 Jun 01; Vol. 6 (6), pp. e2319222. Date of Electronic Publication: 2023 Jun 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Expectations and Prior Experiences Associated With Adverse Effects of COVID-19 Vaccination.

  • Authors : Schäfer I; Institute and Outpatients Clinic of General Practice/Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Oltrogge JH

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Drug-Related Side Effects and Adverse Reactions*

  • Source: JAMA network open [JAMA Netw Open] 2023 Mar 01; Vol. 6 (3), pp. e234732. Date of Electronic Publication: 2023 Mar 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.

  • Authors : Abara WE; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Gee J

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: JAMA network open [JAMA Netw Open] 2023 Feb 01; Vol. 6 (2), pp. e2253845. Date of Electronic Publication: 2023 Feb 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details

×